Eyes
Lifitegrast (ophthalmic) and your FAA medical
Lymphocyte Function-Associated Antigen 1 (LFA-1) Antagonist
Other names: Xiidra
Wait
24 hours
after the first dose
There is more to this wait.
The FAA's MedGuide lists lifitegrast (ophthalmic) (Xiidra) as allowed, for dry eye disease, with a wait of 24 hours after the first dose; after each dose, no flying or safety-related duties while experiencing blurry vision or headache; and none after the final dose, used as prescribed.
Track your medicationsMore detail: lifitegrast (ophthalmic)The rest of Crosscheck's reading, in plain wordsOpen
Wait
- after each dose, no flying or safety-related duties while experiencing blurry vision or headache
The MedGuide defines allowed as acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present, and says wait times are not determined solely by the medication: an extended observation period may be required to verify clinical stability of the condition.
- 24 hours after the first dose: ground observation
Show the FAA's words: lifitegrast (ophthalmic)The official FAA wording: three passages, each with its document and dateOpen
Generic: lifitegrast (ophthalmic)
Brand Name: Xiidra
Drug Class: Lymphocyte Function-Associated Antigen 1 (LFA-1) Antagonist
Underlying Condition: Dry eye disease
Use: ALLOW
INITIAL Wait Time (after first dose): 24 hours
SUBSEQUENT Dose Wait Time (after each dose): Do not fly or perform SRD while experiencing blurry vision or headache.
DISCONTINUATION Wait Time (after final dose): None
Frequency Use Limit: As prescribed
ALLOWED: The medication is acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present.
Underlying Condition: Evaluating medication use requires considering the impact of safety of flight from both the medication and underlying condition. Wait times are not determined solely by the medication; an extended observation period may be required to verify clinical stability of the condition.